Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)



Status:Recruiting
Conditions:Cancer, Cancer, Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:3/16/2015
Start Date:December 2013
End Date:January 2017
Contact:Bhishamjit Chera, MD
Email:bchera@med.unc.edu
Phone:(919) 966-7700

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT)

The purpose of this research study is to determine whether and when patients with human
papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and
chemotherapy clear their human papilloma virus infection.


Inclusion Criteria:

1. ≥ 18 years of age (no upper age limit)

2. AnyT, AnyN, M0 squamous cell carcinoma of the oropharynx

3. Biopsy proven squamous cell carcinoma that is HPV positive via standard pathological
assessment of tumor tissues in pathology department at the treating institution

4. Scheduled for definitive CRT as primary treatment of their oropharynx cancer

Exclusion Criteria:

1. Prior history of radiation therapy to the head and neck

2. Prior history of mucosal head and neck cancer.

3. Not willing or able to comply with study specific procedures
We found this trial at
1
site
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, North Carolina 27599
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials